Craig Bennison

5PUBLICATIONS
22CO-AUTHORS
Epidemiological methodsEconomic models and forecastingCancer therapy (excl. chemotherapy and radiation therapy)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 21, 2024
Cost Effectiveness of Fremanezumab in Episodic and Chronic Migraine Patients from a Japanese Healthcare Perspective.

Takao Takeshima, Fumihiko Sakai, Xinyu Wang

|Nov 11, 2022
Response to Comment on "An Integrated Pharmacokinetic-Pharmacodynamic-Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia".

Marjanne A Piena, Natalie Houwing, Carla W Kraan

|May 25, 2022
Cost-effectiveness analysis of KTE-X19 CAR T therapy versus real-world standard of care in patients with relapsed/refractory mantle cell lymphoma post BTKi in England.

Svenja Petersohn, Gilles Salles, Michael Wang

|Oct 08, 2021
An Integrated Pharmacokinetic-Pharmacodynamic-Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia.

Marjanne A Piena, Natalie Houwing, Carla W Kraan

|Feb 26, 2021
Cost-effectiveness for KTE-X19 CAR T therapy for adult patients with relapsed/refractory mantle cell lymphoma in the United States.

Claire L Simons, Daniel Malone, Michael Wang

Pageof 1

Frequent Collaborators

2 joint publications

Claire L Simons

2 joint publications

Michael Wang

2 joint publications

Sally W Wade

2 joint publications

Marjanne A Piena